Volker Schäfer

1.6k total citations
61 papers, 1.2k citations indexed

About

Volker Schäfer is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, Volker Schäfer has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 17 papers in Molecular Medicine and 15 papers in Epidemiology. Recurrent topics in Volker Schäfer's work include Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Volker Schäfer is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Volker Schäfer collaborates with scholars based in Germany, Slovakia and Austria. Volker Schäfer's co-authors include Thomas A. Wichelhaus, Volker Brade, Klaus‐Peter Hunfeld, Boris Böddinghaus, Peter Kraiczy, Helga Rübsamen‐Waigmann, Hagen von Briesen, Wolfgang Fleischer, K. Reimer and Cathy Royer and has published in prestigious journals such as The American Journal of Medicine, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Volker Schäfer

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volker Schäfer Germany 20 515 271 223 166 144 61 1.2k
Erik Kihlström Sweden 28 290 0.6× 322 1.2× 398 1.8× 109 0.7× 135 0.9× 71 1.8k
Francis Chan Canada 18 285 0.6× 365 1.3× 243 1.1× 169 1.0× 341 2.4× 32 1.2k
Tove Ejlertsen Denmark 19 721 1.4× 201 0.7× 315 1.4× 76 0.5× 56 0.4× 62 1.5k
Paul Chadwick United Kingdom 20 473 0.9× 274 1.0× 413 1.9× 64 0.4× 165 1.1× 98 1.6k
Bor-Shen Hu Taiwan 15 705 1.4× 163 0.6× 240 1.1× 387 2.3× 112 0.8× 30 1.2k
Jaber Aslanzadeh United States 19 331 0.6× 172 0.6× 465 2.1× 80 0.5× 64 0.4× 42 1.1k
R Cisterna Spain 20 469 0.9× 221 0.8× 603 2.7× 190 1.1× 64 0.4× 140 1.4k
Timothy Blackmore New Zealand 19 374 0.7× 171 0.6× 461 2.1× 143 0.9× 79 0.5× 43 1.5k
Carla R. Clausen United States 25 1.1k 2.1× 301 1.1× 409 1.8× 251 1.5× 392 2.7× 40 2.4k
Jette Bangsborg Denmark 24 554 1.1× 433 1.6× 468 2.1× 142 0.9× 171 1.2× 83 1.7k

Countries citing papers authored by Volker Schäfer

Since Specialization
Citations

This map shows the geographic impact of Volker Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Schäfer more than expected).

Fields of papers citing papers by Volker Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Schäfer. The network helps show where Volker Schäfer may publish in the future.

Co-authorship network of co-authors of Volker Schäfer

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Schäfer. A scholar is included among the top collaborators of Volker Schäfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Schäfer. Volker Schäfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bachler, Mirjam, Johannes Bösch, Tobias Hell, et al.. (2020). Impaired fibrinolysis in critically ill COVID-19 patients. British Journal of Anaesthesia. 126(3). 590–598. 76 indexed citations
2.
Schäfer, Volker, et al.. (2007). In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.. International Journal of Antimicrobial Agents. 30(1). 83–86. 4 indexed citations
3.
Fischer, Doris, Alex Veldman, Michael A. Diefenbach, & Volker Schäfer. (2004). Bacterial Colonization of Patients Undergoing International Air Transport: A Prospective Epidemiologic Study. Journal of Travel Medicine. 11(1). 44–48. 19 indexed citations
4.
Reimer, K., Thomas A. Wichelhaus, Volker Schäfer, et al.. (2002). Antimicrobial Effectiveness of Povidone-Iodine and Consequences for New Application Areas. Dermatology. 204(Suppl. 1). 114–120. 87 indexed citations
5.
Wichelhaus, Thomas A., Klaus‐Peter Hunfeld, Boris Böddinghaus, et al.. (2001). Rapid Molecular Typing of Methicillin-ResistantStaphylococcus aureusby PCR-RFLP. Infection Control and Hospital Epidemiology. 22(5). 294–298. 50 indexed citations
6.
Wichelhaus, Thomas A., et al.. (2000). Bedeutung des Methicillin-resistenten S. aureus (MRSA) in der Geriatrie - Epidemiologie, Therapie und Management. Zeitschrift für Gerontologie und Geriatrie. 33(5). 367–373. 1 indexed citations
7.
Wacha, H., U. Schöffel, A. Billing, et al.. (2000). Coverage of Enterococci in Community Acquired Secondary Peritonitis: Results of a Randomized Trial. Surgical Infections. 1(2). 95–107. 36 indexed citations
8.
Hunfeld, Klaus‐Peter, Peter Kraiczy, Thomas A. Wichelhaus, Volker Schäfer, & Volker Brade. (2000). New Colorimetric Microdilution Method for In Vitro Susceptibility Testing of Borrelia burgdorferi Against Antimicrobial Substances. European Journal of Clinical Microbiology & Infectious Diseases. 19(1). 27–32. 33 indexed citations
9.
Krčméry, V., et al.. (1999). Extended-Spectrum β-Lactamase Producing Strains ofEnterobacter cloacaeTransferring Resistance to Cefotaxime and Ceftazidime. Journal of Chemotherapy. 11(2). 97–102. 5 indexed citations
10.
Adamietz, Irenä us A., R Rahn, H.D. Böttcher, et al.. (1998). Prophylaxe der radiochemotherapeutisch bedingten Mukositis : Wertigkeit der prophylaktischen Mundspülung mit PVP-Iodlösung. Strahlentherapie und Onkologie. 174(3). 149–155. 2 indexed citations
11.
Krčméry, V., et al.. (1998). Further Studies of Transferable Antibiotic Resistance in Strains ofPseudomonas aeruginosafrom Four Clinical Settings in Three Countries. Journal of Chemotherapy. 10(3). 215–220. 5 indexed citations
12.
Krčméry, V., et al.. (1996). En BlocTransduction of Imipenem Resistance with Other Resistance Determinants from a Clinical Strain ofPseudomonas aeruginosa. Journal of Chemotherapy. 8(1). 43–46. 4 indexed citations
13.
Krčméry, V., et al.. (1996). Transferable Resistance to Specific Antibiotics in Nosocomial Strains ofPseudomonas aeruginosafrom Two Teaching Hospitals. Journal of Chemotherapy. 8(6). 420–424. 5 indexed citations
14.
Rahn, R, et al.. (1995). PREVENTING POST-TREATMENT BACTEREMIA: COMPARING TOPICAL POVIDONE-IODINE AND CHLORHEXIDINE. The Journal of the American Dental Association. 126(8). 1145–1148. 39 indexed citations
15.
Schäfer, Volker, Hagen von Briesen, Helga Rübsamen‐Waigmann, et al.. (1994). Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. Journal of Microencapsulation. 11(3). 261–269. 47 indexed citations
16.
Schäfer, Volker, et al.. (1993). Preliminary results of an interdisciplinary survey of drug victims. Forensic Science International. 62(1-2). 147–149. 3 indexed citations
17.
Schäfer, Volker, et al.. (1992). In-vitro activity of cefpirome against isolates from patients with urinary tract, lower respiratory tract and wound infections. Journal of Antimicrobial Chemotherapy. 29(suppl A). 7–12. 4 indexed citations
18.
Knothe, H, et al.. (1992). Influence of cefpirome on pharyngeal and faecal flora after single and multiple intravenous administrations of cefpirome to healthy volunteers. Journal of Antimicrobial Chemotherapy. 29(suppl A). 81–86. 4 indexed citations
19.
Shah, P. M., et al.. (1987). Bactericidal Activity of Ofloxacin versus Roxithromycin in the Treatment of Streptococcus pneumoniae. Drugs. 34(Supplement 1). 9–13. 6 indexed citations
20.
Rahn, R, et al.. (1987). [Bacteremia after intraligamental anesthesia].. PubMed. 97(7). 859–63.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Kihlström Breakdown of academic impact, for papers by Francis Chan Breakdown of academic impact, for papers by Tove Ejlertsen Breakdown of academic impact, for papers by Paul Chadwick Breakdown of academic impact, for papers by Bor-Shen Hu Breakdown of academic impact, for papers by Jaber Aslanzadeh Breakdown of academic impact, for papers by R Cisterna Breakdown of academic impact, for papers by Timothy Blackmore Breakdown of academic impact, for papers by Carla R. Clausen Breakdown of academic impact, for papers by Jette Bangsborg
Rankless by CCL
2026